Genzyme Corp. Resources | BNET
On The Insider: Sarah Jessica Parker's Mole Removed

BNET Industries

Genzyme Corp. (GENZ) is in the Pharma Industry

Revenue
Dec 31 2007
$3.8B
Profit
Dec 31 2007
$480.1M
Market Cap
Jul 22 2008
$12.5M

Latest News and Analysis

Additional Resources

  • BullMarket.com Offers Investment Opinion on Biotech Stocks

    PRINCETON, N.J. -- BullMarket.com (http://www.bullmarket.com), an online investment newsletter focused on long-term growth and income-generating stocks, announced today that it has provided subscribers with reports on biotech stocks, including Celgene(Nasdaq: CELG), Genzyme(Nasdaq: GENZ), Gilead Sciences(Nasdaq: GILD), and Amgen(Nasdaq: AMGN), among others. All paid and trial subscribers to BullMarket.com...

    Articles 2008-07-14

  • Research and Markets: Benchmark Genzymes Performance Against Key Rivals in the Ethical Pharmaceutical Sector Today

    DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/2b4f88/genzyme_corporatio) has announced the addition of the "Genzyme Corporation: Pharmavitae Profile" report to their offering. Introduction This analysis examines the historical and forecast performance for Genzyme in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline...

    Articles 2008-07-09

  • Incorporated: 1981
  • CEO: Mr. Henri A. Termeer

Genzyme is a biotechnology company operating in five segments: Renal, which develops, produces and distributes products for patients with renal diseases; Therapeutics, which develops, produces and distributes therapeutic products such as products for treating genetic and other chronic debilitating diseases; Transplant, which develops, producess and distributes therapeutic products for pre-transplantation, prevention and treatment of acute rejection in organ transplantation, and other autoimmune disorders; Biosurgery, which develops, produces and distributes biotherapeutics and biomaterial products; and Genetics, which provides testing services for oncology, prenatal and reproductive markets.

Key Competitors

Genzyme Corp. Company Info

Board of Directors

Mr. Henri A. Termeer

Chairman

Mr. Douglas A. Berthiaume

Ms. Gail Koziara Boudreaux

Mr. Robert J. Carpenter

Dr. Charles L. Cooney Ph.D.

Mr. Richard F. Syron

Dr. Victor J. Dzau M.D.

Senator Cornelius McGillicudy III

Contact Information

500 Kendall Street

Cambridge, MA

http://www.genzyme.com

617 252-7500

NAICS Code

Biological Product (except Diagnostic) Manufacturing: 325414